{"id":"W4401843367","doi":"10.1016/j.jtho.2024.08.017","title":"Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813–819]”","year":2024,"lang":"en","type":"erratum","venue":"Journal of Thoracic Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; BC Cancer Agency; Saskatchewan Cancer Agency; CancerCare Manitoba; Alberta Cancer Foundation; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Mesothelioma; Randomized controlled trial; General surgery; Cancer; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007504949,0.002004629,0.002619918,0.002262015,0.002802552,0.002960239,0.002819946,0.007398232,0.08178802],"category_scores_gemma":[0.04559918,0.001316913,0.003268095,0.001738576,0.001145118,0.001540803,0.0009640519,0.01077339,0.03394092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005981923,"about_ca_system_score_gemma":0.01103908,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03016297,"about_ca_topic_score_gemma":0.06399903,"domain_scores_codex":[0.9947333,0.001289969,0.0009216524,0.0004188454,0.002149591,0.000486574],"domain_scores_gemma":[0.9753523,0.009811413,0.002463171,0.0006341132,0.009939985,0.001798987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002315834,0.00001159987,0.00004048957,0.0001101898,0.00001847481,0.00003527551,0.000002804006,0.00001273706,0.00001887282,0.0000816042,0.9974025,0.002033736],"study_design_scores_gemma":[0.003507238,0.0002882575,0.001916076,0.001038861,0.0003684705,0.0001942101,0.00003785641,0.0002546578,0.0003405137,0.001095951,0.9908856,0.00007238895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0005824954,0.004744641,0.0006759011,0.3047559,0.6459669,0.0007155689,0.02426291,0.0006959484,0.01759965],"genre_scores_gemma":[0.007734916,0.006975806,0.002985999,0.6131511,0.1813086,0.001960495,0.02343471,0.000632302,0.1618161],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.969837,"threshold_uncertainty_score":0.2736082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02542463279865098,"score_gpt":0.4198140239372365,"score_spread":0.3943893911385856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}